Qrem — Seed (estimated) · €450K

Avançsa, the Generalitat de Catalunya's investment holding, gave Qrem a €450K participative loan under its Innova Creixement line. Qrem ran a €450K capital increase alongside it, so the round totals €900K of equity plus debt. The money is for growing Q-Cytokine sales, cutting production costs and extending the treatment to more conditions. The investors in the equity part were not disclosed. The date is the month only, estimated from when Avançsa's LinkedIn announcement was posted (about late January 2023).